HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19)
|קרן||National Institutes of Health (NIH)|
|תאריכים נוספים||13/10/2021 |
|פקולטה||Life Sciences, Medicine|
The goal of this grant is to support team-based research projects to develop assays, screening and early optimization work to develop a non-addictive therapeutic to treat pain. Applications should propose a plan that will lead to the development of analgesics with a rigorous biological rationale and scientifically sound assays. If the data does not currently exist, the application must include a strong plan for developing data linking the putative therapeutic target(s) to the proposed pain indication and supporting the hypothesis that altering the target activity will produce desirable outcomes for the disease.
This call is not specific for any one or group of pain conditions. Projects to develop therapeutics for acute pain, chronic pain, painful neuropathy, musculoskeletal pain, headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, eye pain, sickle-cell pain, post-surgical pain, cancer pain, visceral pain, post stroke pain, myofascial pain, painful disorders of the orofacial region and other conditions will be considered.
Funding: $1,500,000 per year
Duration: 5 years
Research Authority due dates: 10 days prior to submission
LOI (encouraged) due dates: 27.3.21, 22.5.21, 13.9.21, 9.5.22, 11.9.22, 9.5.23, 10.9.23
Full proposal due dates: 27.4.21, 22.6.21, 13.10.21, 9.6.22, 11.10.22, 9.6.23, 10.10.23
|עדכון אחרון||עדכון אחרון: 14/03/2021|